This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
11/18/2024
Good afternoon, and welcome to Syntec Optics Holdings Inc.' 's third quarter earnings call. My name is Drake, and I'll be your operator for today's call. As a reminder, this conference call is being recorded. At this time, all participants are in a listen-only mode. I'll now turn the call over to Dean Rudy, Syntec Optics Chief Financial Officer. Please go ahead.
Thank you, Operator, and welcome everyone to Cintiq Optics Q3 earnings call. Al Kapoor, Chairman and Chief Executive Officer of Cintiq Optics, will join me today for a call to discuss the company's financial and operational results for the third quarter of 2024. Here are a few quick reminders before we start. First, today's call is being webcast and our press release can be accessed along with it on the investor section of our company website, www.syntechoptics.com. Second, we'll make forward-looking statements based on current expectations during this call. Actual results may differ due to factors noted in today's release or in our periodic SEC filings. Finally, we will reference some non-GAAP financial measures. Reconciliations to the nearest corresponding GAAP measure are included in today's release and on our website. With that, I will turn the call over to Alex.
Thank you, Dean, and thank you to everyone joining us today for Syntec Optics earnings call. Syntec strategy is the same as we described in the last earnings call. I will discuss more details in this call on how we are executing that strategy. As discussed before, Syntec Optics strategy is to lead large yet often overlooked markets for light-enabled products by offering a diverse product portfolio tailored to blue chip customers' needs. This approach leverages our operational strengths and is built upon a solid financial foundation. To achieve this, we are focusing on the following things that I have described before. We will grow by having a big target addressable market, and we have talked about light-enabled goods now at about 11% of the global economy. Now, within the large target market, we add acyclical end markets, which are more recession resistant markets. And what we've done so far is we've added communications to defense, biomedical and consumer sectors that we had. We will leverage existing strengths in such end markets by utilizing our existing customer base, market presence, and operational capabilities to support all new product launches capitalizing on our unique ability across horizontal diverse technologies. Employee retention will complement our leverage of strengths. We aim to maintain one in five employees with over 10 years experience, continuing our commitment to being the best place to work in our community. We will continue to build relationships with Blue Chip customers and expand our business with industry leaders across all end markets, including new products in spaces, optics, and biomedical optics. Our ability to be strong supply chain partners makes us a safe and dependable choice for their high-precision products that we manufacture. We will continue to develop products across core capabilities, enhancing our competitive advantage by building on 20 years of innovation, manufacturing expertise, trade secrets, and patents. We are executing Syntec's strategy by continuing to be leading provider of mission-critical products to advanced technology defense biomedical communications equipment manufacturers. Our operations span the development of advanced manufacturing processes, the design and assembly of mission-critical optics, the integration of these products and other innovative ancillary components into sub-assemblies for subsystems, and then marketing and selling them into diverse set of markets which I already mentioned, biomedical, disposable medical, defense, consumer, communications, and markets. We market mission-critical optics through our blue chip advanced technology integrators and OEM customers who rely on optoelectronics, light-enabled devices, and intelligence that requires high-precision reliability. We have a 90,000 square foot facility in upstate New York, vertically and horizontally integrated where we are headquartered. Syntec wins in the marketplaces because our customers appreciate our unique ability to achieve tough specifications at benchmark cost by deploying our patent portfolio and our trade secrets combined with our proprietary manufacturing capabilities. Before discussing our organic and inorganic growth opportunities and some of our other operational highlights, I will turn the call back to Dean to review our financials and operational results.
You're reading a preview of the OPTX Q3 2024 earnings call.
Free account.
